Does sodium 4-phenylbutyrate affect prtein aggregates formation?
Best insight from top research papers
Sodium 4-phenylbutyrate does not appear to be mentioned in any of the provided abstracts.
Answers from top 3 papers
More filters
| Papers (3) | Insight |
|---|---|
| The given information does not mention anything about the effect of sodium 4-phenylbutyrate on protein aggregates formation. | |
2 Citations | The paper does not provide information about the effect of sodium 4-phenylbutyrate on protein aggregate formation. |
| The given text does not provide any information about the effect of sodium 4-phenylbutyrate on protein aggregate formation. |
Related Questions
What causes aggregation of alpha-synuclein?4 answersThe aggregation of alpha-synuclein (αSyn) can be triggered by various factors. One potential cause is the binding of an RNA secondary structure called G-quadruplex (G4RNA) to αSyn, leading to a liquid-to-solid phase transition and subsequent aggregation. Additionally, environmental factors like Staphylococcus aureus-produced functional amyloids, known as phenol soluble modulins (PSMαs), can catalyze the aggregation of αSyn through heterogeneous primary nucleation, potentially initiating synucleinopathies. Furthermore, certain mutations in the αSyn protein can increase its susceptibility to oligomerization and fibrillation, contributing to its aggregation and pathogenicity in diseases like Parkinson's. The presence of negatively charged surfactants like sodium dodecyl sulphate (SDS) can also stimulate αSyn aggregation by reducing electrostatic repulsion and promoting β-sheet structure formation.
Does 4-phenylbutyrate decrease protein aggregates?4 answers4-phenylbutyrate has been shown to decrease protein aggregates in multiple studies. It has been found to successfully decrease the formation of protein aggregates and prevent the progression of cell apoptosis in trisomic neurons. However, a recent study suggests that 4-phenylbutyrate does not promote protein folding nor prevent aggregation. Another study found that a derivative of 4-phenylbutyrate, 2-isopropyl-4-phenylbutanoic acid, was more effective than 4-phenylbutyrate in reducing protein aggregation. In the context of amyotrophic lateral sclerosis (ALS), two derivatives of 4-phenylbutyrate, C4 and C5, successfully inhibited amyloid aggregation of mutant SOD1 but failed to suppress the accumulation of misfolded SOD1. Overall, while 4-phenylbutyrate and its derivatives have shown promise in reducing protein aggregates in certain contexts, further research is needed to optimize their effectiveness as therapeutic agents for neurodegenerative diseases.
What results were obtained studying antibody aggregation ?5 answersAntibody aggregation was studied in several papers. One study found that high concentration antibody solutions with rich multimers had a deeper color, indicating the presence of multimers. LC-MS analysis showed that the multimers had a complex structure and ICP-MS analysis revealed a higher concentration of iron ions in the multimers. Another study used in silico analysis to investigate antibody aggregation and found that the presence of glycans in the Fc region of antibodies influenced the aggregation prone regions (APR) of the antibodies. A third study investigated the effect of hydrodynamic flow and solid-liquid interfaces on protein aggregation and found that changes in the materials of the syringe barrels had a dramatic effect on protein aggregation, while increasing shear rate had a negligible effect. A fourth study used numerical simulations to study the hydrodynamic behavior of antibodies near silicone oil-water interfaces and found that protein loss from the bulk solution occurred as the molecules adsorbed at the interface. Finally, a study investigated the interaction of immunoglobulin G (IgG) antibodies with gold nanoparticles (AuNPs) and found that the addition of antibody triggered the aggregation of AuNPs at pH < 7.5, while a stable bioconjugate was formed at pH ≥ 7.5.
What are the factors that affect the formation of aggregates?5 answersThe factors that affect the formation of aggregates include size-dependent diffusivity, rotational effects, settling under gravity, capillary pressure, interparticle attractive forces, charge heterogeneity, particle polarization, arbuscular mycorrhizal fungi (AMF), and pH value. Size-dependent diffusivity and rotational effects can slow down the growth rate of aggregates and decrease their fractal dimension. Capillary pressure can overwhelm repulsive electrostatic forces, leading to the assembly of aggregates that are out of thermal equilibrium. Charge heterogeneity and particle polarization can significantly alter the mechanical equilibrium of aggregates and hold particles together with electrostatic forces. AMF can influence the formation and stability of soil aggregates, with different AMF species having different effects. pH value can affect the morphology, physico-chemical properties, formation kinetics, and stability of amyloid and amyloid-like aggregates.
How do fibrillar aggregates form in BTA based molecules?5 answersFibrillar aggregates in BTA-based molecules form through self-assembly processes. In concentrated solutions of amphiphilic macromolecules with a local helical structure, a deterioration in solvent quality leads to the formation of intermolecular fibrillar helix bundles with approximately the same lengths and aggregation numbers. Similarly, copolymers of amino acids, such as Glatiramer, can also form amyloid-like fibrils in aqueous solutions despite their random sequence structure. The all-alpha helix multi-domain protein bovine serum albumin (BSA) can aggregate at elevated temperatures and form well-ordered beta-sheet rich aggregates with significant amounts of alpha-helix structure. In decane solutions of homoditopic heterocomplementary monomers, fibrillar supramolecular aggregates with a persistence length of approximately 18 nm are formed through sextuple hydrogen-bond-mediated self-assemblies. Additionally, fibrillar molecular aggregates formed by self-assembly of small hydrophobic molecules can prevent the growth of microtubules, providing a mechanism for inhibiting the growth of cancer cells.
How do fibrillar aggregates form in benzene-1,3,5-tricarboxamide (BTA) based molecules?5 answersFibrillar aggregates in benzene-1,3,5-tricarboxamide (BTA) based molecules form through self-assembly processes. The formation of these aggregates is influenced by various factors such as the structure of the molecule, the presence of specific functional groups, and the nature of the solvent. For example, the presence of small non-bulky terminal amine salt in BTA derivatives induces self-assembly into twisted one-dimensional higher-order nanofibers. Additionally, the presence of appropriate metal ions can promote the formation of long and stable filaments with a cross-sectional diameter of 12 nm. The self-assembly behavior of BTA molecules can also be influenced by the presence of alkyl chains and polyethylene glycol (PEG) chains, resulting in the formation of distinct nanostructures such as micelles, nanotapes, and nanoribbons. Overall, the self-assembly of BTA molecules into fibrillar aggregates is a complex process that depends on multiple factors and can lead to the formation of diverse nanostructures with different morphologies and functionalities.